Stifel reiterates Inspire Medical Systems stock rating on Q3 beat

Markets Investing.com By Investing.com 03 Nov 2026 14:44 1 min read
Stifel reiterates Inspire Medical Systems stock rating on Q3 beat

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Tracked from this story

Wells Fargo’s $69 target on $INSP is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.

Wells Fargo’s track record →

Tracked from this story

Stifel’s $85 target on $INSP is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.

Stifel’s track record →

Tracked from this story

Truist Securities’s $76 target on $INSP is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.

Truist Securities’s track record →

Call it yourself

No member calls on $INSP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Inspire Medical Systems →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.